Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @SyneosHealth
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SyneosHealth
-
Employee Photo of the Month: Welcome aboard! Our team in Sydney recently hosted a new hire orientation to welcome some of our newest employees to the Syneos Health family.
: Zoë Healeyhttps://www.linkedin.com/posts/zoegardiner_clinicalresearch-syneoshealth-myworkmatters-activity-6623796278990082048-VRGB …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to
@Syneoscomms for receiving two awards from the@PMSociety Awards last Friday. Their work on the Think Ink campaign for@Immunocore won the gold Craft Award for Disease Awareness (HCPs) and silver for Film & Animations (HCPs).#pmawardspic.twitter.com/SMLfPcjQ82
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@leighhouse is quoted in@fiercepharma discussing the important role more than 43.5 million caregivers in the U.S. play when it comes to the future of pharmahttps://www.fiercepharma.com/marketing/remember-caregivers-pharma-should-increase-focus-growing-group-critical-stakeholders …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The use of
#realworldevidence is expanding to design, test and review#raredisease treatments, but market access challenges persist as payers in the U.S. and Europe continue to express doubts. Our recent survey sheds light on the perception gap. https://www.syneoshealth.com/insights-hub/real-world-value-advancing-payer-understanding-rwe-rare-disease …pic.twitter.com/RtX3Zay38k
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health invests in Microsoft/Indegene platform via
@pharmaphorum https://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/ …pic.twitter.com/FsppmLw0jd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health proslijedio/la je Tweet
For brand teams, launch year has become a nightmare of denials, delays and deep discounts. Click to download a paper on optimizing pharmaceutical launch from Syneos Health Consulting, in collaboration with
@Pharma_Intell: https://pages.pharmaintelligence.informa.com/syneos-health-white-paper-download?src=Marketing%20Campaign …#pharmalaunch#pharma#payerspic.twitter.com/gaWMaTq0jm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For additional insight, click here to download a paper on optimizing
#pharmaceutical launch from Syneos Health Consulting: https://pages.pharmaintelligence.informa.com/syneos-health-white-paper-download?src=Marketing%20Campaign …pic.twitter.com/Mzzt6rDbHT
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Recent research from Syneos Health Consulting shows that less than half of newly approved drugs appeared on formulary in their launch year. What’s a
#drugdeveloper to do? Listen for ways to prepare the best possible access outcome http://www.buzzsprout.com/85116/2566813-denials-delays-and-deep-discounts-in-pharmaceutical-launch …pic.twitter.com/jPd4wuKXBf
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health proslijedio/la je Tweet
In this
@SyneosHealth podcast, authors of our book "Why We Resist," explore key principles of behavior, the#behavioralscience of segmentation, & how#healthcare communicators can apply both to move customers from a position of resistance to activation. https://www.syneoshealth.com/insights-hub/syneos-health-podcast-why-we-resist …pic.twitter.com/RfjWsLfrd5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Go behind the scenes to learn how our
#Trends2020 report - with insights from 200 experts across our global network - comes to life. http://bit.ly/2ROkGfq pic.twitter.com/TMiQOIrAbG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
At Syneos Health, there’s no shortage of challenging work, learning and opportunities. Click below to explore ways you can grow your career in an evolving, global company that is always looking for ways to work smarter and more efficiently.
#clinicalcareers#healthcarejobsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Get up to speed on Module V of the Good Pharmacovigilance Practices (GVP) of the European Medicines Agency (EMA) during this
@xtalks webinar which will review practical applications and case studies.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Patientrecruitment is often challenging, especially for#raredisease clinical trials. Just-in-time site activation can help bridge the gap, but is it really effective? We break it down in the@mySCRS InSite Magazine: https://cloud.3dissue.com/180561/181052/211361/InSiteWinter2019/index.html?page=18 …pic.twitter.com/ZhwJuO3PEB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health proslijedio/la je Tweet
Hear this
@SyneosHealth#podcast with Jessica Shull, European Lead for the Digital Therapeutics Alliance, an international non-profit trade association of industry leaders & stakeholders engaged in evidence-driven advancement of#digitaltherapeutics. https://buzzsprout.com/85116/2263109-the-digital-therapeutics-alliance-a-european-perspective …#DTxHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
#clinicaldata transparency landscape is shifting as U.S. and global regulations evolve. Join Vidhi Vashisht of@kinapseglobal, a Syneos Health company, for this insightful session at Clinical Data Disclosure, Transparency & Plain Language Summaries. https://informaconnect.com/clinical-data-disclosure-and-transparency/ …pic.twitter.com/9AB8cAwlr6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health proslijedio/la je Tweet
Experts from
@SyneosHealth ask whether there's still reason to be positive about the future of digital therapeutics in the latest issue of Deep Dive https://bit.ly/2siNKCT pic.twitter.com/OJTowsDJZi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The word relationship is often used in regard to
#pharma’s emerging connections with#patients, but should it be?@leighhouse says it's more like "person-level relevance" - read more in@FiercePharmahttps://www.fiercepharma.com/marketing/direct-to-patient-pharma-adopting-more-digital-tools-create-closer-connections-to …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can
#pharma companies learn to communicate value for today’s new medicines? At@Phacilitate Leaders World, we will review best practices from recent launches and share the new playbook for#healthcare communications on the runway to market.#PLW2020 http://bit.ly/2uVDdyB pic.twitter.com/gakFM7OJe0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
That's a wrap on Day 2 of #BiotechShowcase. Check out our recap including the release of a new payer survey on DTx and live coverage of our pricing, policy and payers panel.https://twitter.com/i/moments/1217348926434447367 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.